Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

34.49
Delayed Data
As of 4:00pm ET
 -0.30 / -0.86%
Today’s Change
25.27
Today|||52-Week Range
263.81
-66.07%
Year-to-Date

Today’s Trading

Previous close34.79
Today’s open34.70
Day’s range33.17 - 35.36
Volume24,624,028
Average volume (3 months)21,839,735
Market cap$11.9B
Dividend yield--
Data as of 4:00pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+21.88%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+43.22%
P/E ratioNM
Price/Sales5.93
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+1.72+2.50%
BMRNBiomarin Pharmaceuti...-1.40-1.70%
PRGOPerrigo Company PLC+1.37+1.43%
MDVNMedivation Inc+0.16+0.27%
Data as of 4:14pm ET, 05/05/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)$1.37
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs